KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.
Clarke K, Basser RL, Underhill C, Mitchell P, Bartlett J, Cher L, Findlay M, Dalley D, Pell M, Byrne M, Geldard H, Hill JS, Maher D, Fox RM, Green MD, Kaye AH.
Clarke K, et al. Among authors: fox rm.
J Clin Oncol. 1999 Aug;17(8):2579-84. doi: 10.1200/JCO.1999.17.8.2579.
J Clin Oncol. 1999.
PMID: 10561325
Clinical Trial.